Nine drug company chiefs are charged with conspiracy to defraud NHSBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7546.872-c (Published 13 April 2006) Cite this as: BMJ 2006;332:872
- Owen Dyer
Nine British pharmaceutical executives have been charged with conspiracy to defraud the NHS, after an investigation by the Serious Fraud Office into price fixing of generic drugs.
Five companies have also been charged with colluding to keep prices high: Goldshield Group, Kent Pharmaceuticals, Norton Healthcare, Generics (UK), and Ranbaxy (UK). All the companies and individuals charged deny wrongdoing.
The Serious Fraud Office's inquiry, dubbed Operation Holbein, is one of its biggest ever cases, involving up to 150 investigators. Officers raided six companies in 2002. One, Regent-GM Laboratories, has since been wound up. The other five are those charged last week. …
Log in using your username and password
Log in through your institution
Sign up for a free trial